These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 15868188

  • 1. Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models.
    Dube A, Singh N, Sundar S, Singh N.
    Parasitol Res; 2005 Jun; 96(4):216-23. PubMed ID: 15868188
    [Abstract] [Full Text] [Related]

  • 2. Antimony susceptible Leishmania donovani: evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era.
    Ghosh S, Verma A, Kumar D, Deep DK, Ramesh V, Salotra P, Singh R.
    Microbiol Spectr; 2024 Jun 04; 12(6):e0402623. PubMed ID: 38712926
    [Abstract] [Full Text] [Related]

  • 3. Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.
    Sinha R, Roychoudhury J, Palit P, Ali N.
    Antimicrob Agents Chemother; 2015 Jan 04; 59(1):344-55. PubMed ID: 25367907
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani.
    Carter KC, Mullen AB, Sundar S, Kenney RT.
    Antimicrob Agents Chemother; 2001 Dec 04; 45(12):3555-9. PubMed ID: 11709339
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
    Das VN, Ranjan A, Bimal S, Siddique NA, Pandey K, Kumar N, Verma N, Singh VP, Sinha PK, Bhattacharya SK.
    Natl Med J India; 2005 Dec 04; 18(3):131-3. PubMed ID: 16130613
    [Abstract] [Full Text] [Related]

  • 10. Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice.
    Roychoudhury J, Sinha R, Ali N.
    PLoS One; 2011 Mar 10; 6(3):e17376. PubMed ID: 21423750
    [Abstract] [Full Text] [Related]

  • 11. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
    Escobar P, Yardley V, Croft SL.
    Antimicrob Agents Chemother; 2001 Jun 10; 45(6):1872-5. PubMed ID: 11353640
    [Abstract] [Full Text] [Related]

  • 12. Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy.
    Carter KC, Hutchison S, Boitelle A, Murray HW, Sundar S, Mullen AB.
    Parasitology; 2005 Dec 10; 131(Pt 6):747-57. PubMed ID: 16336728
    [Abstract] [Full Text] [Related]

  • 13. The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India.
    Singh N, Chatterjee M, Sundar S.
    Parasit Vectors; 2014 Dec 17; 7():596. PubMed ID: 25515494
    [Abstract] [Full Text] [Related]

  • 14. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
    Lira R, Sundar S, Makharia A, Kenney R, Gam A, Saraiva E, Sacks D.
    J Infect Dis; 1999 Aug 17; 180(2):564-7. PubMed ID: 10395884
    [Abstract] [Full Text] [Related]

  • 15. Drug unresponsiveness & combination therapy for kala-azar.
    Jha TK.
    Indian J Med Res; 2006 Mar 17; 123(3):389-98. PubMed ID: 16778318
    [Abstract] [Full Text] [Related]

  • 16. Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.
    Samant M, Sahasrabuddhe AA, Singh N, Gupta SK, Sundar S, Dube A.
    Parasitology; 2007 Aug 17; 134(Pt 9):1175-84. PubMed ID: 17362540
    [Abstract] [Full Text] [Related]

  • 17. Drug resistance in Indian visceral leishmaniasis.
    Sundar S.
    Trop Med Int Health; 2001 Nov 17; 6(11):849-54. PubMed ID: 11703838
    [Abstract] [Full Text] [Related]

  • 18. Comparison of treatment regimens of kala-azar based on culture & sensitivity of amastigotes to sodium antimony gluconate.
    Thakur CP, Thakur S, Narayan S, Sinha A.
    Indian J Med Res; 2008 Jun 17; 127(6):582-8. PubMed ID: 18765878
    [Abstract] [Full Text] [Related]

  • 19. Studies on stibanate resistant Leishmania donovani isolates of Indian origin.
    Pal S, Mandal A, Duttagupta S.
    Indian J Exp Biol; 2001 Mar 17; 39(3):249-54. PubMed ID: 11495284
    [Abstract] [Full Text] [Related]

  • 20. Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis.
    Bhandari V, Kulshrestha A, Deep DK, Stark O, Prajapati VK, Ramesh V, Sundar S, Schonian G, Dujardin JC, Salotra P.
    PLoS Negl Trop Dis; 2012 Mar 17; 6(5):e1657. PubMed ID: 22629478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.